Isocaloric Dietary Restriction vs. Bariatric Surgery for Obesity Treatment

NCT ID: NCT04024540

Last Updated: 2024-08-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

72 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-07-23

Study Completion Date

2024-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a prospective, randomized, two-armed study to assess the efficacy and safety of isocaloric dietary restriction in the treatment of obese without diabetic for a period of 4 weeks.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a randomized, open-label, two arms trial. Based on inclusion and exclusion criteria, 72 eligible patients, who are 18-45 years old, with BMI between 35 to 45kg/m2 are assigned to one of two intervention groups: isocaloric dietary restriction; bariatric surgery. Both groups were given a dietary intervention for a period of 4 weeks (in rigorous supervision confined in inpatient department). The main purpose of this study is to clarify the efficacy of isocaloric dietary restriction, compared to bariatric surgery, in losing weight and improving metabolic factors. This is an investigator-initiated study performed by department of endocrinology and metabolic disease, Ruijin hospital affiliated with Shanghai Jiaotong University School of Medicine.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

isocaloric dietary restriction

Very low caloric diet 400 kcal/d for a week, 600 kcal/d for another week and 800 kcal/d for 2 weeks.

Group Type EXPERIMENTAL

isocaloric dietary restriction

Intervention Type DIETARY_SUPPLEMENT

Very low caloric diet

Bariatric surgery

Laparoscopic vertical sleeve gastrectomy

Group Type ACTIVE_COMPARATOR

isocaloric dietary restriction

Intervention Type DIETARY_SUPPLEMENT

Very low caloric diet

Bariatric surgery

Intervention Type PROCEDURE

Laparoscopic vertical sleeve gastrectomy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

isocaloric dietary restriction

Very low caloric diet

Intervention Type DIETARY_SUPPLEMENT

Bariatric surgery

Laparoscopic vertical sleeve gastrectomy

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age between 18 to 45 years old
* 35 ≤ BMI ≤ 45 kg/m2

Exclusion Criteria

* Obesity induced by other endocrinologic disorders
* Severe gastrointestinal diseases or contraindication for surgery
* History or newly known of diabetes
* Use of hypoglycemic medications, antibiotic in the preceding 2 months, or yogurt within 5 days
* Weight change more than 5% of body weight within the past 3 months
* Severe or unstable cardiovascular, liver or renal diseases or known cancer
* History of drug or alcohol abuse or other substance abuse
* Any mental disorders or current use of antidepressantsPregnancy or lactation or consideration of pregnancy
* Allergies to specific food ingredients in the intervention
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shanghai Jiao Tong University School of Medicine

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Wang Weiqing

professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Weiqing Wang, M.D. Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Shanghai Clinic Center for Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Institute for Endocrine and Metabolic Diseases

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ruijin hospital, Shanghai Jiaotong University School of Medicine

Shanghai, Shanghai Municipality, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Ruijin-2019-34

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Development of Obesity and Bariatric Surgery
NCT03296605 ENROLLING_BY_INVITATION